USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN´S DISEASE: RESULTS FROM A WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL

Silvio Danese  ¹     Severine Vermeire  ²     Geert R. D'Haens  ³     Julian Panés  ⁴     Axel Dignass  ⁵     Fernando Magro  ⁶     Maciek Nazar  ⁷     Manuela Le Bars  ⁸     Marjolein Lahaye  ⁹     Lioudmila Ni  ¹⁰     Daniel R. Gaya  ¹¹     Laurent Peyrin-Biroulet  ^12    
1 Humanitas University, Milan, Italy
² University Hospitals Leuven, Leuven, Belgium
³ Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
⁴ Hospital Clinic of Barcelona, IDIBPAS, CIBERehd, Barcelona, Spain
⁵ Agaplesion Markus Hospital, Frankfurt/Main, Germany
⁶ Institute for Molecular and Cell Biology, Faculty of Medicine University of Porto, Porto, Portugal
⁷ Janssen-Cilag Polska Sp. z .o.o., Warsaw, Poland
⁸ Janssen-Cilag, Issy Les Moulineaux, France
⁹ Janssen-Cilag BV, Breda, Netherlands
¹⁰ Janssen-Cilag Russia, Moscow, Russian Federation
¹¹ Glasgow Royal Infirmary, Glasgow, United Kingdom
¹² University Hospital of Nancy, University of Lorraine, Houdemont, France

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)